698-25018-10080
2 vaccinations
5 coded responses
12 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 328 / FL
- Registered
- 2021-09-28
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-07
Dose 1 — Pfizer-BioNTech
-
2021-09-28
Registered in v-safe
-
2021-09-28
Dose 2 — Pfizer-BioNTech
- 2021-09-28
-
2021-09-30
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia, Paraesthesia, Vision blurred — Feeling: Good · Site: PainFree text: First shot: tingling and numbness from elbow to finger tips for 2 1/2 days and blurred visionMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
-
2021-10-02
Survey response — days 1–6 daily, dose 2MedDRA: Dry mouth, Oropharyngeal pain — Feeling: FairFree text: Sore throat. Have noticed mouth is more dry since taking the dosesI just consume more water.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
- 2021-10-12
- 2021-10-19
-
2021-10-26
Survey response — day 28, dose 2MedDRA: Thirst — Feeling: GoodFree text: Sustained increase of thirst with no other knownhealth changes.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-11-09
-
2021-12-28
Survey response — 3 months, dose 2MedDRA: Dysmenorrhoea, Menstrual disorder, Menstruation irregular, Thirst — Feeling: GoodFree text: Ongoing thirst. Need to drink additional water throughout the day. Changes in mo they menstrual cycle (eg, timing of PMS varied by month, severity of cramps to no cramps).MedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Survey response — 6 months, dose 2MedDRA: Contusion, Fatigue — Feeling: Poor · Be unable to work or attend schoolFree text: Increased unexplained bruising and unexplained fatigue.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-07 | Pfizer-BioNTech | No |
| 2 | 2021-09-28 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): First shot: tingling and numbness from elbow to finger tips for 2 1/2 days and blurred vision
Systemic reaction (other): Sore throat. Have noticed mouth is more dry since taking the dosesI just consume more water.
Release 10 — day 28, dose 2
Symptoms: Sustained increase of thirst with no other knownhealth changes.
Release 10 — 3 months, dose 2
Symptoms: Ongoing thirst. Need to drink additional water throughout the day. Changes in mo they menstrual cycle (eg, timing of PMS varied by month, severity of cramps to no cramps).
Release 11 — 6 months, dose 2
Symptoms: Increased unexplained bruising and unexplained fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Contusion | · | · | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Thirst | · | · | ✓ |
| SRO | Dry mouth | · | · | ✓ |
| SRO | Hypoaesthesia | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
| SRO | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release